Viewing Study NCT04544995


Ignite Creation Date: 2025-12-24 @ 2:00 PM
Ignite Modification Date: 2025-12-27 @ 10:16 PM
Study NCT ID: NCT04544995
Status: TERMINATED
Last Update Posted: 2025-07-16
First Post: 2020-09-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module